Hi BulbaMan,
Saneron CCEL Therapeutics, mentioned in the last paragraph, is 43% owned by Cryo-Cell (CCEL). CCEL is primarily in the umbilical cord stem cell storage business and is making money. IMHO, their research arm, Saneron, increases CCEL's potential.
FD: I own CCEL and am quite bullish on the stock.
I used to follow CCEL a few years ago, until I found out that many of the cord blood banks were being sued for patent infringement, any update on that? Thanks. I think cord blood stem cells, have a lot of potential.
Personally,I'm financially biased towards Macropore Biosurgery, using adipose tissue for a source of regenerative cells. It was developed by the president, Dr. Marc Hedrick. There are numerous "potential" advantages for using adipose tissue.
macropore.com
We'll see if they come to fruition...bwdik?
Best of Luck,
SS |
